Groningen, The Netherlands – 28 October 2025 – InnoCore Pharmaceuticals (“InnoCore”), a leading specialist in long-acting injectable (LAI) drug delivery technologies, attended and presented at the PODD: Partnership Opportunities in Drug Delivery Conference, taking place between 27–28 October 2025 in Boston, MA.
CBO, Martin Bakker and CTO, Rob Steendam represented InnoCore at the conference and presented a session on InnoCore’s proprietary SynBiosys® platform and its unique differentiation in formulating peptides and complex biologics into long-acting injectable (LAI) therapies.
The presentation covered key features of SynBiosys®, biodegradable polymeric drug delivery platform that preserves molecular integrity, enables linear release over weeks to months, and supports both early-stage development and commercial manufacture of fragile molecules like Biologics and Peptides.
InnoCore’s formulation expertise covers a broad range of Active Pharmaceutical Ingredient (API) classes, with a growing focus on the biologics and peptide space where SynBiosys®’ properties provide clear differentiation and creates unique value for its partners.
-Ends-
For more information, please contact:
Notes to Editors
About InnoCore Pharmaceuticals
InnoCore Pharmaceuticals is a leading drug delivery development provider, formulating peptide and biologic APIs into scalable, biodegradable and tunable Long Acting Injectable (LAI) dosage forms.
The Company’s proprietary polymeric drug delivery platform, SynBiosys®, overcomes the significant technical challenges of translating these complex and fragile molecules into LAI drug products that maintain their essential bioactive characteristics.
Dosage forms can be created for early proof of concept, through to clinical trial usage in an easy-to-scale cGMP form. These formulations can be adapted for use in local or systematic injectable forms for a wide range of therapeutic applications, such as osteoarthritis, rheumatology, oncology, CNS, infectious and cardiometabolic diseases.
InnoCore is a true strategic partner to its biopharma customers working hand-in-hand with them to lay strong foundations for future clinical and commercial success. InnoCore is innovating biologic drug formulation for better treatment outcomes and compliance.
For more information, please see: www.innocorepharma.com.